RNASE3 analysis is instrumental in identifying and validating novel biomarkers for various inflammatory diseases, guiding the development of new diagnostic and prognostic tools.
The full promise of precision medicine hinges on advanced biomarker analysis. Creative Biolabs offers extensive services for protein biomarker quantification, characterization, and gene analysis. We're dedicated to in-depth ribonuclease 3 (RNASE3) analysis, aiming to uncover vital biomarker signatures for our clients.
RNASE3, commonly known as eosinophil cationic protein (ECP), is a highly basic and potent cytotoxic single-chain zinc-containing protein prominently found within the primary matrix of eosinophil granulocytes. This remarkable molecule consists of a single polypeptide chain of 133 amino acids, with its initial 40 amino acids being crucial for its membrane-interfering, heparin-binding, and cytotoxic activities.
RNASE3, commonly known as eosinophil cationic protein (ECP), is a highly basic and potent cytotoxic single-chain zinc-containing protein prominently found within the primary matrix of eosinophil granulocytes. This remarkable molecule consists of a single polypeptide chain of 133 amino acids, with its initial 40 amino acids being crucial for its membrane-interfering, heparin-binding, and cytotoxic activities. Serum RNASE3 has been widely recognized as a pivotal marker reflecting the activation state of eosinophils in conditions like asthma, often correlating directly with the severity of airway inflammation. Furthermore, extensive studies have collectively concluded that serum RNASE3 serves as an independent and significant biomarker for various cardiovascular and pulmonary conditions, including coronary artery disease (CAD), acute exacerbation of chronic obstructive pulmonary disease (AECOPD), coronary slow flow (CSF), and Churg-Strauss syndrome (CSS).
Fig.1 RNASE3's specific influences on various cell types and microorganisms in vitro. (Bystrom, 2011)
At Creative Biolabs, we deliver comprehensive and precise RNASE3 analysis services designed to meet your specific research and diagnostic needs. Our offerings include advanced quantification of RNASE3 protein levels, detailed characterization of its binding capacities, assessment of its functional activities, and in-depth analysis of its molecular heterogeneity. We provide a tailored approach to ensure optimal results for your unique samples and research objectives.
RNASE3 can specifically bind with high affinity to the bacteria-wall components. The binding capacity to lipopolysaccharides (LPSs), lipid A, and peptidoglycans (PGNs) could be analyzed by a fluorescent displacement assay, and the corresponding dissociation constants could be calculated using the protein labeled with a fluorophore.
The ability of RNASE3 protein to depolarize the bacteria cytoplasmic membrane provides a direct assessment of their effect at the membrane inner level.
ELISA kits are normally used to measure the concentrations of plasma RNASE3. Creative Biolabs has developed a sensitive and specific enzyme immunoassay by using our own native RNASE3 protein and high-quality antibody materials.
Due to glycosylation of the protein, the molecular mass of RNASE3 can differ between 16 and 22 kDa. RNASE3 heterogeneity could be studied using an affinity capture assay with the surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) technique.
Our RNASE3 analysis services follow a streamlined and client-focused workflow to ensure efficiency and precision:
Our expert team engages in a detailed discussion with you to understand your specific research goals, sample types, and desired outcomes. We collaboratively design a customized analysis plan tailored to your project.
You provide us with your biological samples (e.g., serum, plasma, sputum, tissue lysates). Strict guidelines are provided for sample preparation and shipment to maintain integrity.
Upon receipt, samples undergo rigorous quality control checks and appropriate processing steps, including purification or extraction, to prepare them for downstream analysis.
We perform the agreed-upon RNASE3 analyses, utilizing high-sensitivity ELISA for quantification, fluorescent displacement assays for binding capacity, membrane depolarization assays for functional assessment, and SELDI-TOF MS for heterogeneity analysis.
Raw data is meticulously generated, processed, and subjected to stringent quality assurance protocols to ensure accuracy and reliability.
Our bioinformaticians and biologists meticulously analyze the data, providing insightful interpretations and comprehensive reports that include detailed methodologies, results, and conclusions, delivered in a clear and actionable format.
RNASE3 analysis is instrumental in identifying and validating novel biomarkers for various inflammatory diseases, guiding the development of new diagnostic and prognostic tools.
Accurate quantification of RNASE3 levels allows for the effective monitoring of disease activity, therapeutic response, and progression in conditions like asthma, allergic rhinitis, and autoimmune disorders.
By understanding RNASE3's functional roles, researchers can identify it as a potential therapeutic target, facilitating the development of precision interventions for eosinophil-driven inflammatory conditions.
RNASE3 analysis provides crucial insights into the innate immune response, helping to elucidate the mechanisms of host defense against pathogens and the dynamics of inflammation.
We employ high-sensitivity ELISA kits for RNASE3 quantification, enabling the detection of even extremely low concentrations of the protein in biological samples, which is crucial for early disease detection and monitoring subtle changes in disease states and therapeutic responses, even at baseline levels.
Yes, our RNASE3 Heterogeneity Analysis, utilizing techniques like affinity capture coupled with mass spectrometry, can identify and characterize different molecular mass variants of RNASE3, often arising from varying glycosylation patterns, providing deeper insights into its biological roles and potential post-translational modifications.
Our RNASE3 analysis services are primarily designed for research use only, providing robust data for scientific investigation and biomarker discovery rather than for routine clinical diagnostic procedures, ensuring our focus remains on generating novel insights and advancing scientific understanding.
We implement rigorous quality control measures throughout the entire RNASE3 analysis workflow, including internal standards, calibration curves, and replicate analyses, all designed to ensure the highest levels of accuracy and reproducibility for your critical data and reliable conclusions, meeting stringent research standards.
Absolutely, our services are highly customizable; you can select specific RNASE3 analysis techniques, such as quantification, functional assays, or heterogeneity analysis, based on your unique research objectives and budgetary considerations, ensuring a perfectly aligned service that maximizes your research investment.
Our functional assays for RNASE3 assess its biological activity by measuring its binding capacity to microbial components like LPS and peptidoglycans using fluorescent displacement, and its ability to depolarize bacterial membranes, providing insights into its innate immune roles and potential as a novel therapeutic target in inflammatory pathways.
Creative Biolabs provides dedicated post-delivery support, where our scientific team is available to answer any questions regarding your RNASE3 analysis report, discuss further experimental design, or offer additional consultations to maximize your research outcomes and ensure long-term success in your scientific endeavors.
Our biomarker analysis service is furnished for research use only. Not for use in diagnostic procedures. If you want to order custom analysis services, please feel free to contact us for more information.
Reference
For Research Use Only.